Eric C. Burton, M.D.

Eric C. Burton, M.D.

  • Center for Cancer Research
  • National Cancer Institute
Neuro-Oncology Branch


Dr. Burton is a neuro-oncologist who provides care for adults with primary brain tumors. His particular research interest is determining the optimal treatment for older patients with primary brain tumors. As a member of the Neuro-Oncology Branch (NOB), he applies his extensive neuro-oncology experience to developing research projects that utilize population-based data analysis to answer difficult clinical questions. He also develops clinical trials in various sub-populations, such as geriatric patients. The overarching goal of Dr. Burton’s research is to provide the best possible care to all brain tumor patients, while also determining the best regimen for each individual—keeping in mind their cognitive, functional, and physiological limitations due to the disease.

Explore the NOB's Research Programs >

Areas of Expertise

Brain Tumors
Clinical Trials
Geriatric Oncology

Information for Patients

Learn more about our clinical trials and the highly specialized care teams that lead them.


Selected Key Publications

The Impact of Timing of Adjuvant Therapy on Survival for Patients with Glioblastoma: An analysis of the National Cancer Database.

Amsbaugh M, Yusuf M, Gaskins J, Burton E, Woo S
Journal of Clinical Neuroscience. 66: 92-99, 2019. [ Journal Article ]

Survival in elderly patients with glioblastoma in the USA: A comparison of bevacizumab-based and non-bevacizumab-based regimens

Davies J, Reyes-Rivera I, Pattipaka T, Skirboll S, Ugiliweneza B, Woo S, Boakye M, Abrey L, Garcia J, Burton E
Neuro-Oncology Practice. 5(4): 251-261, 2018. [ Journal Article ]

Survival Impact of Prolonged Radiation Therapy for Patients with Glioblastoma Treated with Combined-Modality Therapy

Yusuf M, Gaskins J, Amsbaugh M, Woo S, Burton E
Neuro-Oncology Practice. 6(2): 112-123, 2018. [ Journal Article ]

Interim Results of a Phase II Study of Hypofractionated Radiotherapy with Concurrent Temozolomide Followed by Adjuvant Temozolomide in Patients Over 70 Years Old with Newly Diagnosed Glioblastoma

Yusuf M, Ugiliweneza B, Amsbaugh M, Boakye M, Williams B, Nelson M, Hattab EM, Woo S, Burton E
Oncology. 95(1): 39-42, 2018. [ Journal Article ]